EcoDrugPlus

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSHCOG00000019605
Gene Symbol: RPS4X
3 Cross references
495 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSHCOG00000007396
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSHCOG00000012302
Gene Symbol: RPS7
3 Cross references
357 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSHCOG00000009150
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSHCOG00000020779
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSHCOG00000009232
Gene Symbol: RPSA
4 Cross references
515 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSHCOG00000011775
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSHCOG00000015713
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSHCOG00000001790
Gene Symbol: LOC109510536
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Aurora-2-Like

Ensembl ID : ENSHCOG00000001197
Gene Symbol: LOC109510652
3 Cross references
233 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSHCOG00000007630
Gene Symbol: LOC109511823
3 Cross references
246 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3-Like

Ensembl ID : ENSHCOG00000017204
Gene Symbol: LOC109530110
3 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).